Related Experiment Video

Updated: Jul 7, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

The tyrphostin B42 inhibits cell proliferation and HER-2 autophosphorylation in cervical carcinoma cell lines

Isabel Soto-Cruz1, Rosalva Rangel-Corona, Arturo Valle-Mendiola

  • 1Laboratory of Oncology, Research Unit in Cell Differentiation and Cancer, Facultad de Estudios Superiores Zaragoza, Iztapalapa, México.

Cancer Investigation
|February 9, 2008
PubMed

Insights

The human epidermal growth factor receptor 2 (HER2) is crucial in cervical cancer. Tyrphostin B42 effectively inhibits HER2 signaling, suppressing cervical cancer cell growth by blocking HER2 phosphorylation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The human epidermal growth factor receptor 2 (HER2) is vital for cell growth and differentiation.
  • HER2 overexpression is linked to uncontrolled growth in various cancers, including cervical carcinoma.
  • Understanding HER2's role is critical for developing targeted therapies for cervical cancer.

Purpose of the Study:

  • To investigate the role of HER2 in cervical carcinoma.
  • To assess the efficacy of Tyrphostin B42, an epithelial growth factor receptor inhibitor, on cervical cancer cell lines.
  • To elucidate the mechanism by which Tyrphostin B42 affects HER2 signaling and cell proliferation.

Main Methods:

  • Flow cytometry to detect HER2 protein expression in CALO and INBL cervical carcinoma cell lines.
  • Crystal violet assay to evaluate the effect of Tyrphostins on cell growth.
  • Western blot analysis to determine the phosphorylation status of HER2.

Main Results:

  • HER2 protein expression was confirmed in CALO and INBL cell lines.
  • Tyrphostin B42 significantly inhibited cervical carcinoma cell growth in vitro within 72 hours at micromolar concentrations.
  • Tyrphostin B42 reduced HER2 phosphorylation, indicating inhibition of the HER2 signal-regulated kinase pathway.

Conclusions:

  • Tyrphostin B42 demonstrates potent anti-proliferative effects on cervical carcinoma cell lines.
  • The inhibition of cervical cancer cell growth by Tyrphostin B42 is mediated through the suppression of HER2 protein kinase signaling.
  • Targeting HER2 signaling with inhibitors like Tyrphostin B42 represents a promising therapeutic strategy for cervical cancer.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.